AI Revolutionizes IVF in India

Artificial Intelligence (AI) is increasingly integrated into fertility treatments across India, enhancing IVF procedures. Clinics are adopting AI-based tools to assist embryologists in selecting embryos with a higher likelihood of successful pregnancy.

Traditionally, embryo selection relied on visual assessment of shape and quality. AI now analyzes thousands of embryo images and genetic data, identifying subtle patterns related to growth and potential implantation success. Some systems estimate polygenic risk scores for certain diseases, though these are probability estimates, not diagnoses.

Approximately two to three lakh IVF cycles occur annually in India, with AI being utilized for embryo assessment and implantation prediction. This adoption is driven by rising conception delays due to lifestyle factors and medical conditions. However, ethical and legal frameworks, including the ART and PCPNDT Acts, strictly regulate embryo testing in India.

Indian law permits genetic testing for serious inherited disorders like Thalassaemia but strictly prohibits sex selection or the creation of 'designer babies.' Violators face severe penalties, including imprisonment and license cancellation. AI's role is supportive, not a replacement for medical expertise, and it cannot guarantee pregnancy outcomes.

Concerns exist about overpromising AI capabilities, such as predicting intelligence or beauty. Current AI applications primarily focus on embryo selection and identifying risks for severe diseases. The challenge for Indian doctors lies in balancing innovation with ethics, patient safety, and legal compliance.

The responsible use of AI in IVF aims to improve fertility care by making embryo selection more efficient and objective, supporting couples in achieving healthy pregnancies safely and ethically within India's legal boundaries.